Joseph L Shaker, MD | Medical College of Wisconsin

Joseph L. Shaker, MD

Staff Physician

view physician profile

Locations

Community Memorial Hospital
Froedtert Hospital
Waukesha Memorial Hospital
North Hills Health Center - Specialty Clinics
Osteoporosis and Calcium Disorders
Mequon Health Center

Specialties

Endocrinology

Languages

English

Secondary Appointments

Internal Medicine
Endocrinology, Diabetes and Metabolism

Contact Information

Research Interests

Dr. Shaker is an endocrinologist with interests in calcium and bone disorders. He is a co-founder of the Wisconsin Bone Club, an annual two-day meeting that features speakers and attendees in the fields of endocrinology and rheumatology in addition to other specialists interested in bone and calcium disorders. He has authored or co-authored 40 journal articles and 39 scientific abstracts.

His research interests include high or low blood calcium and parathyroid disorders, osteoporosis associated with intestinal disease or surgery, and calcium and bone disorders. Dr. Shaker is a member of the editorial boards of Endocrine Practice and the Journal of Clinical Densitometry. He is on the board of directors of the Paget Foundation for Paget’s Disease of Bone and Related Disorders and has served on the board of directors of the International Society for Clinical Densitometry (ISCD).

Parathyroidectomy for primary hyperparathyroidism improves sleep quality: A prospective study.

(La J, Wang TS, Hammad AY, Burgardt L, Doffek K, Carr AA, Shaker JL, Carroll TB, Evans DB, Yen TW.) Surgery. 2017 01;161(1):25-34.
Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.

(Poonuru S, Findling JW, Shaker JL.) Osteoporos Int. 2016 12;27(12):3645-3649.
Recent developments in osteogenesis imperfecta.

(Shaker JL, Albert C, Fritz J, Harris G.) F1000Res. 2015;4(F1000 Faculty Rev):681.
Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation.

(Tutton S, Olson E, King D, Shaker JL.) J Clin Endocrinol Metab. 2012 Oct;97(10):3421-5.
Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

(Shaker JL.) Ther Adv Musculoskelet Dis. 2009 Apr;1(2):107-25.
Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.

(Ichikawa S, Imel EA, Sorenson AH, Severe R, Knudson P, Harris GJ, Shaker JL, Econs MJ.) J Clin Endocrinol Metab. 2006 Nov;91(11):4472-5.
Evolution of a pheochromocytoma.

(Magill SB, Fritsche CM, Klinger DE, Tector AJ, Shaker JL.) Endocr Pract. 2006 Sep-Oct;12(5):545-51.
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.

(Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ.) J Clin Endocrinol Metab. 2006 Jun;91(6):2055-61.
Osteoporosis associated with excess glucocorticoids.

(Shaker JL, Lukert BP.) Endocrinol Metab Clin North Am. 2005 Jun;34(2):341-56, viii-ix.
Calcium and Phosphate Homeostasis.

(Shaker JL and Deftos L. .) ENDOTEXT.org.. .
Low 24-hour urine calcium levels in patients with sporadic primary hyperparathyroidism: Is further evaluation warranted prior to parathyroidectomy?

(O’Connell K, Yen TW, Shaker J, Wilson SD, Evans DB, Wang TS.) American Journal of Surgery 2015;210:123-128.. .
Heterotopic ossification in the mesentery following abdominal surgery

(Kidambi S, Poll M, Kaplan FS, Gannon FH, and Shaker JL. .) The Endocrinologist 2006;16:323-328.. .